113 related articles for article (PubMed ID: 7506000)
1. A stromelysin assay for the assessment of metalloprotease inhibitors on human aggregated proteoglycan.
Doughty JR; Goldberg RL; Ganu V; Melton RA; Hu SI; Di Pasquale G
Agents Actions; 1993; 39 Spec No():C151-3. PubMed ID: 7506000
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies recognizing protease-generated neoepitopes from cartilage proteoglycan degradation. Application to studies of human link protein cleavage by stromelysin.
Hughes CE; Caterson B; White RJ; Roughley PJ; Mort JS
J Biol Chem; 1992 Aug; 267(23):16011-4. PubMed ID: 1379586
[TBL] [Abstract][Full Text] [Related]
3. Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase.
Hughes C; Murphy G; Hardingham TE
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):733-9. PubMed ID: 1659387
[TBL] [Abstract][Full Text] [Related]
4. Effects of stromelysin activity on proteoglycan degradation of canine articular cartilage explants.
Todhunter RJ; Yeh LA; Sheldon A; Grisanzio L; Walker SL; Burton-Wurster N; Lust G
Am J Vet Res; 1995 Sep; 56(9):1241-7. PubMed ID: 7486406
[TBL] [Abstract][Full Text] [Related]
5. Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation.
Bayne EK; MacNaul KL; Donatelli SA; Christen A; Griffin PR; Hoerrner LA; Calaycay JR; Ayala JM; Chapman K; Hagmann W
Arthritis Rheum; 1995 Oct; 38(10):1400-9. PubMed ID: 7575690
[TBL] [Abstract][Full Text] [Related]
6. Degradation of proteoglycan aggregate by a cartilage metalloproteinase. Evidence for the involvement of stromelysin in the generation of link protein heterogeneity in situ.
Nguyen Q; Murphy G; Roughley PJ; Mort JS
Biochem J; 1989 Apr; 259(1):61-7. PubMed ID: 2719651
[TBL] [Abstract][Full Text] [Related]
7. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis.
Xie DL; Hui F; Meyers R; Homandberg GA
Arch Biochem Biophys; 1994 Jun; 311(2):205-12. PubMed ID: 8203882
[TBL] [Abstract][Full Text] [Related]
8. In vivo activity of human recombinant tissue inhibitor of metalloproteinases (TIMP). Activity against human stromelysin in vitro and in the rat pleural cavity.
Lark MW; Saphos CA; Walakovits LA; Moore VL
Biochem Pharmacol; 1990 Jun; 39(12):2041-9. PubMed ID: 2353943
[TBL] [Abstract][Full Text] [Related]
9. In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1 beta.
Hutchinson NI; Lark MW; MacNaul KL; Harper C; Hoerrner LA; McDonnell J; Donatelli S; Moore V; Bayne EK
Arthritis Rheum; 1992 Oct; 35(10):1227-33. PubMed ID: 1418008
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.
Fosang AJ; Neame PJ; Hardingham TE; Murphy G; Hamilton JA
J Biol Chem; 1991 Aug; 266(24):15579-82. PubMed ID: 1874716
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody that recognizes hyaluronic acid binding region of aorta proteoglycans.
Radhakrishnamurthy B; Jeansonne N; Tracy RE; Berenson GS
Atherosclerosis; 1993 Jan; 98(2):179-92. PubMed ID: 7681290
[TBL] [Abstract][Full Text] [Related]
12. Increased stromelysin-1 (MMP-3), proteoglycan degradation (3B3- and 7D4) and collagen damage in cyclically load-injured articular cartilage.
Lin PM; Chen CT; Torzilli PA
Osteoarthritis Cartilage; 2004 Jun; 12(6):485-96. PubMed ID: 15135145
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors.
Bottomley KM; Borkakoti N; Bradshaw D; Brown PA; Broadhurst MJ; Budd JM; Elliott L; Eyers P; Hallam TJ; Handa BK; Hill CH; James M; Lahm HW; Lawton G; Merritt JE; Nixon JS; Röthlisberger U; Whittle A; Johnson WH
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):483-8. PubMed ID: 9163342
[TBL] [Abstract][Full Text] [Related]
14. Sensitivity of monoclonal antibody, 5-D-4, for the detection of aggrecan, aggrecan fragments, and keratan sulfate.
Saphos CA; Dey P; Lark MW; Moore VL
Agents Actions; 1993; 39 Spec No():C154-6. PubMed ID: 7506001
[TBL] [Abstract][Full Text] [Related]
15. Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis.
Yocum SA; Lopresti-Morrow LL; Gabel CA; Milici AJ; Mitchell PG
Arch Biochem Biophys; 1995 Feb; 316(2):827-35. PubMed ID: 7864640
[TBL] [Abstract][Full Text] [Related]
16. Immunological analysis of proteoglycan structural changes in the early stage of experimental osteoarthritic canine cartilage lesions.
Pelletier JP; Martel-Pelletier J; Mehraban F; Malemud CJ
J Orthop Res; 1992 Jul; 10(4):511-23. PubMed ID: 1377239
[TBL] [Abstract][Full Text] [Related]
17. Purification of the neutral proteoglycan-degrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3.
Gunja-Smith Z; Nagase H; Woessner JF
Biochem J; 1989 Feb; 258(1):115-9. PubMed ID: 2930500
[TBL] [Abstract][Full Text] [Related]
18. Studies on purified neutral proteoglycan-degrading enzyme (stromelysin/matrix metalloproteinase 3) from human articular cartilage.
Gunja-Smith Z; Nagase H; Woessner JF
Matrix Suppl; 1992; 1():82-3. PubMed ID: 1480097
[No Abstract] [Full Text] [Related]
19. Activation of neutral metalloprotease in human osteoarthritic knee cartilage: evidence for degradation in the core protein of sulphated proteoglycan.
Martel-Pelletier J; Pelletier JP; Malemud CJ
Ann Rheum Dis; 1988 Oct; 47(10):801-8. PubMed ID: 3196082
[TBL] [Abstract][Full Text] [Related]
20. Immunodetection and characterization of the degradation of cartilage proteoglycans in vitro and in vivo.
Poole AR; Witter J; Roberts N; Roughley PJ; Webber C; Campbell I
J Rheumatol; 1987 May; 14 Spec No():80-2. PubMed ID: 3625678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
